Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration/File PhotoCOVID-19 vaccine sales more than tripled to $894 million in the second quarter from the previous three months, and the drugmaker updated its 2021 forecasts on Thursday to include sales from its Alexion unit.
The Anglo-Swedish company has also delayed its application to U.S. authorities for approval of the vaccine to the second half of this year. Previously, AstraZeneca was hoping to file it within the first half. The vaccine, invented by Oxford University and hailed a milestone in the fight against the pandemic, has faced several setbacks, including production delays and possible links to some rare, but severe side-effects that are being probed by regulators.The company, which has said it will not make a profit from the shot during the pandemic, updated its financial guidance to include the recent closing of its deal to buy rare medicines business Alexion.
It now expects total revenue to increase by a low-twenties percentage this year, and core earnings of $5.05 per share to $5.40 per share. The forecast does not includes sales from the vaccine. Total revenue rose 25% to $8.22 billion for the three months to June on a constant-currency basis, while core earnings came in at 90 cents per share, compared with analysts' consensus forecasts of 92 cents on sales of $7.58 billion.Our Standards:Subscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
Guess what? I’m a loser ! Without losers there would be no winners.... looking at the bright side ... by the way I have black blood running through my veins... nothing you can do ..... IM PROUD!!
Out of every bad thing that happenes, there's always someone or company that makes lots of money,,,
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AstraZeneca says Covid-19 vaccine showed no increased incidence of rare blood clots after second doseThe estimated rate of thrombosis with thrombocytopenia syndrome was 2.3 for every million vaccines, with incidence rates comparable to those among... Strong sell JohnsonJohnson Astrazenaca thanks Of course not. If one give you clots then more would not give you mow clotting.
Source: MarketWatch - 🏆 3. / 97 Read more »
New Zealand gives provisional nod to AstraZeneca's COVID-19 vaccineNew Zealand's health regulator Medsafe has granted provisional approval for the AstraZeneca COVID-19 vaccine for individuals 18 years of age and older, acting minister for COVID-19 response, Dr Ayesha Verrall, said on Thursday. jacindaardern What was needed now? Wait 2/3 years. Then make similar decisions. Be wise and follow ScottMorrisonMP. You keep embarrassing humanity right now. minhealthnz NZParliament GovGeneralNZ younglabournz MSNBC
Source: Reuters - 🏆 2. / 97 Read more »
Supply issues to delay Moderna COVID-19 vaccine shipments-S.Korean officialModerna (MRNA.O) has pushed back its late-July vaccine shipment schedule for South Korea to August due to supply problems that will affect other countries waiting on Moderna shots, a South Korean health official said on Tuesday. Developing countries like: 😫 Apparently they’re going to Samsung employees instead of the general public. Serves them right I guess.
Source: Reuters - 🏆 2. / 97 Read more »
Pfizer Raises Full-Year Outlook on Covid-19 Vaccine SalesThe pharmaceutical company’s Covid-19 vaccine co-developed with BioNTech contributed $7.8 billion to Pfizer’s total sales of $18.98 billion in the latest quarter. Shocking...and people think it's not all about the dollar. 😂🤦♂️😳 Well people are awake now, they'll fail badly now Go get your free shot, y'all
Source: WSJ - 🏆 98. / 63 Read more »
How Good Are Covid-19 Vaccines At Protecting Against The Delta Variant?Bottom line: All of the vaccines authorized for use in the U.S. are still very effective against the variant and greatly reduce the risk of severe disease, hospitalization or death. It depends...
Source: Forbes - 🏆 394. / 53 Read more »
U.S. viewership of Tokyo Games climbs to 19.8 mln on 2nd nightPrime-time viewership for NBC's broadcast of the Summer Olympics from Tokyo picked up some steam in the first two nights of competition, compared with a lackluster audience for Friday's opening ceremony, preliminary ratings data showed on Monday. 'Choking is nothing to celebrate. It’s perfectly human, and there’s no need to condemn and ridicule her. But who wants to watch an Olympics broadcast where the announcers gaslight you into believing choking is an act of bravery? GOATs don’t choke'
Source: Reuters - 🏆 2. / 97 Read more »